Concepts (192)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Peritoneal Dialysis | 24 | 2019 | 46 | 6.980 |
Why?
| | Kidney Failure, Chronic | 33 | 2019 | 596 | 6.160 |
Why?
| | Renal Dialysis | 25 | 2018 | 256 | 5.540 |
Why?
| | Hemodialysis, Home | 8 | 2017 | 21 | 2.330 |
Why?
| | Arteriovenous Shunt, Surgical | 4 | 2017 | 46 | 1.510 |
Why?
| | Anemia | 3 | 2015 | 58 | 1.280 |
Why?
| | Catheterization, Central Venous | 5 | 2017 | 66 | 1.250 |
Why?
| | Peritoneal Dialysis, Continuous Ambulatory | 6 | 2014 | 9 | 0.950 |
Why?
| | Nephrology | 4 | 2015 | 27 | 0.890 |
Why?
| | Ultrafiltration | 2 | 2017 | 11 | 0.880 |
Why?
| | Dialysis Solutions | 6 | 2006 | 9 | 0.880 |
Why?
| | Prospective Payment System | 3 | 2015 | 11 | 0.840 |
Why?
| | Peritonitis | 3 | 2019 | 12 | 0.770 |
Why?
| | Humans | 47 | 2019 | 29210 | 0.740 |
Why?
| | Health Facility Administrators | 1 | 2017 | 7 | 0.730 |
Why?
| | Hypotension | 1 | 2017 | 43 | 0.730 |
Why?
| | Patient Readmission | 4 | 2019 | 103 | 0.730 |
Why?
| | Catheter-Related Infections | 2 | 2014 | 13 | 0.670 |
Why?
| | Blood Vessel Prosthesis Implantation | 1 | 2016 | 75 | 0.660 |
Why?
| | Hematinics | 2 | 2014 | 6 | 0.660 |
Why?
| | Catheterization, Peripheral | 1 | 2015 | 30 | 0.640 |
Why?
| | Education, Medical, Continuing | 1 | 2015 | 58 | 0.640 |
Why?
| | Patient Selection | 5 | 2011 | 278 | 0.620 |
Why?
| | Attitude of Health Personnel | 1 | 2017 | 179 | 0.620 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2016 | 228 | 0.560 |
Why?
| | Patient Compliance | 2 | 2014 | 220 | 0.540 |
Why?
| | Gentamicins | 1 | 2012 | 4 | 0.520 |
Why?
| | Anti-Infective Agents, Local | 1 | 2012 | 12 | 0.520 |
Why?
| | Mupirocin | 1 | 2012 | 3 | 0.520 |
Why?
| | Clinical Competence | 1 | 2015 | 311 | 0.520 |
Why?
| | Antibiotic Prophylaxis | 1 | 2012 | 16 | 0.520 |
Why?
| | Retrospective Studies | 11 | 2019 | 2996 | 0.520 |
Why?
| | Health Services for the Aged | 1 | 2011 | 29 | 0.490 |
Why?
| | Water-Electrolyte Imbalance | 2 | 2018 | 6 | 0.470 |
Why?
| | Middle Aged | 20 | 2019 | 11505 | 0.430 |
Why?
| | Anti-Bacterial Agents | 1 | 2012 | 289 | 0.420 |
Why?
| | United States | 10 | 2019 | 3675 | 0.410 |
Why?
| | Peritoneum | 3 | 2003 | 27 | 0.400 |
Why?
| | Male | 22 | 2019 | 18702 | 0.380 |
Why?
| | Female | 22 | 2019 | 18961 | 0.380 |
Why?
| | Risk Factors | 8 | 2018 | 3657 | 0.380 |
Why?
| | Hemofiltration | 2 | 2004 | 5 | 0.340 |
Why?
| | Treatment Outcome | 9 | 2017 | 3201 | 0.340 |
Why?
| | Time Factors | 8 | 2017 | 2144 | 0.330 |
Why?
| | Prevalence | 5 | 2016 | 967 | 0.330 |
Why?
| | Hospitalization | 2 | 2018 | 358 | 0.320 |
Why?
| | Hemoglobins | 2 | 2015 | 46 | 0.320 |
Why?
| | Erythropoietin | 2 | 2015 | 28 | 0.320 |
Why?
| | Aged | 13 | 2019 | 10001 | 0.320 |
Why?
| | Kidney | 2 | 2016 | 480 | 0.310 |
Why?
| | Cohort Studies | 5 | 2018 | 1724 | 0.300 |
Why?
| | Glucose | 2 | 2004 | 182 | 0.300 |
Why?
| | Societies, Medical | 1 | 2005 | 148 | 0.290 |
Why?
| | Incidence | 4 | 2019 | 1143 | 0.280 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2003 | 468 | 0.280 |
Why?
| | Forecasting | 2 | 2017 | 140 | 0.280 |
Why?
| | Practice Guidelines as Topic | 4 | 2011 | 383 | 0.270 |
Why?
| | Biomedical Research | 1 | 2005 | 173 | 0.270 |
Why?
| | Biological Transport, Active | 1 | 2002 | 10 | 0.270 |
Why?
| | Age Factors | 4 | 2016 | 1197 | 0.260 |
Why?
| | Guideline Adherence | 2 | 2014 | 108 | 0.260 |
Why?
| | Heart Failure | 2 | 2019 | 629 | 0.260 |
Why?
| | Comorbidity | 2 | 2016 | 553 | 0.250 |
Why?
| | Prospective Studies | 7 | 2017 | 2051 | 0.230 |
Why?
| | Adult | 10 | 2019 | 8631 | 0.210 |
Why?
| | Risk Assessment | 4 | 2019 | 1367 | 0.210 |
Why?
| | Hemodialysis Units, Hospital | 1 | 2018 | 2 | 0.210 |
Why?
| | Aged, 80 and over | 5 | 2016 | 3927 | 0.210 |
Why?
| | Pulmonary Edema | 1 | 2018 | 7 | 0.200 |
Why?
| | Medicare | 3 | 2017 | 187 | 0.190 |
Why?
| | Quality of Life | 3 | 2016 | 857 | 0.180 |
Why?
| | Heparin | 1 | 2017 | 81 | 0.180 |
Why?
| | Anticoagulants | 1 | 2017 | 131 | 0.170 |
Why?
| | Hospital Mortality | 1 | 2017 | 192 | 0.160 |
Why?
| | Manikins | 1 | 2015 | 32 | 0.160 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 2016 | 120 | 0.160 |
Why?
| | Education, Nursing | 1 | 2014 | 2 | 0.160 |
Why?
| | Severity of Illness Index | 3 | 2011 | 910 | 0.160 |
Why?
| | Treatment Failure | 2 | 2007 | 169 | 0.160 |
Why?
| | Nurses | 1 | 2014 | 13 | 0.150 |
Why?
| | Educational Measurement | 1 | 2015 | 115 | 0.150 |
Why?
| | Universities | 1 | 2015 | 127 | 0.150 |
Why?
| | Catheters, Indwelling | 1 | 2014 | 37 | 0.150 |
Why?
| | Diabetic Nephropathies | 1 | 2016 | 242 | 0.140 |
Why?
| | Apolipoproteins | 1 | 2016 | 223 | 0.140 |
Why?
| | Lipoproteins, HDL | 1 | 2016 | 278 | 0.140 |
Why?
| | Antihypertensive Agents | 1 | 2016 | 373 | 0.140 |
Why?
| | Ambulatory Care Facilities | 1 | 2013 | 48 | 0.130 |
Why?
| | Oleanolic Acid | 1 | 2012 | 1 | 0.130 |
Why?
| | Catheter Ablation | 1 | 2013 | 65 | 0.130 |
Why?
| | Kidney Transplantation | 2 | 2016 | 356 | 0.130 |
Why?
| | Pseudomonas | 1 | 2012 | 6 | 0.130 |
Why?
| | Enterobacteriaceae | 1 | 2012 | 11 | 0.130 |
Why?
| | Urea | 2 | 2002 | 34 | 0.130 |
Why?
| | Staphylococcus aureus | 1 | 2012 | 41 | 0.130 |
Why?
| | Carcinoma, Renal Cell | 1 | 2013 | 83 | 0.130 |
Why?
| | Nephrectomy | 1 | 2013 | 103 | 0.130 |
Why?
| | Creatinine | 2 | 2002 | 188 | 0.120 |
Why?
| | Restless Legs Syndrome | 1 | 2011 | 2 | 0.120 |
Why?
| | Life Expectancy | 1 | 2011 | 21 | 0.120 |
Why?
| | Kidney Neoplasms | 1 | 2013 | 145 | 0.120 |
Why?
| | Combined Modality Therapy | 1 | 2012 | 584 | 0.110 |
Why?
| | Insurance, Health, Reimbursement | 1 | 2009 | 16 | 0.110 |
Why?
| | Serum Albumin | 1 | 2010 | 53 | 0.110 |
Why?
| | North Carolina | 2 | 2014 | 1679 | 0.110 |
Why?
| | Health Services Accessibility | 1 | 2011 | 239 | 0.100 |
Why?
| | Hypertension | 1 | 2016 | 990 | 0.100 |
Why?
| | Health Care Costs | 1 | 2009 | 105 | 0.100 |
Why?
| | Survival Rate | 1 | 2011 | 859 | 0.100 |
Why?
| | Cardiovascular Diseases | 1 | 2016 | 1078 | 0.100 |
Why?
| | Program Development | 1 | 2008 | 87 | 0.100 |
Why?
| | Postoperative Complications | 1 | 2013 | 657 | 0.090 |
Why?
| | African Americans | 1 | 2016 | 1627 | 0.090 |
Why?
| | Research Design | 2 | 2012 | 289 | 0.090 |
Why?
| | Hyperparathyroidism, Secondary | 1 | 2005 | 2 | 0.080 |
Why?
| | Diabetes Mellitus | 1 | 2010 | 425 | 0.080 |
Why?
| | Parathyroidectomy | 1 | 2005 | 13 | 0.080 |
Why?
| | Glucans | 1 | 2004 | 1 | 0.080 |
Why?
| | Osmosis | 1 | 2004 | 5 | 0.080 |
Why?
| | Sweetening Agents | 1 | 2004 | 10 | 0.080 |
Why?
| | Amino Acids | 1 | 2004 | 42 | 0.080 |
Why?
| | Multivariate Analysis | 2 | 2019 | 700 | 0.080 |
Why?
| | Carotid Artery Diseases | 1 | 2005 | 128 | 0.070 |
Why?
| | Calcinosis | 1 | 2005 | 176 | 0.070 |
Why?
| | Energy Intake | 1 | 2004 | 129 | 0.070 |
Why?
| | Permeability | 1 | 2003 | 10 | 0.070 |
Why?
| | Equipment Failure | 1 | 2003 | 20 | 0.070 |
Why?
| | Prognosis | 2 | 2019 | 1440 | 0.070 |
Why?
| | Coronary Disease | 1 | 2005 | 234 | 0.070 |
Why?
| | Catheterization | 1 | 2003 | 63 | 0.070 |
Why?
| | Aging | 1 | 2011 | 964 | 0.070 |
Why?
| | Bacterial Infections | 1 | 2003 | 39 | 0.070 |
Why?
| | Proportional Hazards Models | 2 | 2017 | 772 | 0.070 |
Why?
| | Metabolic Clearance Rate | 1 | 2003 | 23 | 0.070 |
Why?
| | Mexico | 1 | 2003 | 85 | 0.070 |
Why?
| | Anthropometry | 1 | 2003 | 85 | 0.070 |
Why?
| | Fluid Therapy | 1 | 2002 | 27 | 0.070 |
Why?
| | Clinical Protocols | 1 | 2003 | 102 | 0.070 |
Why?
| | Nutritional Status | 1 | 2003 | 72 | 0.070 |
Why?
| | Canada | 1 | 2002 | 51 | 0.070 |
Why?
| | Anuria | 1 | 2002 | 2 | 0.070 |
Why?
| | Vitamin B 12 | 1 | 2002 | 10 | 0.060 |
Why?
| | Inulin | 1 | 2002 | 5 | 0.060 |
Why?
| | beta 2-Microglobulin | 1 | 2002 | 8 | 0.060 |
Why?
| | Molecular Weight | 1 | 2002 | 38 | 0.060 |
Why?
| | Health Care Surveys | 1 | 2003 | 191 | 0.060 |
Why?
| | Drug Therapy, Combination | 1 | 2003 | 312 | 0.060 |
Why?
| | Costs and Cost Analysis | 1 | 2002 | 90 | 0.060 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2012 | 1574 | 0.060 |
Why?
| | Patient Participation | 1 | 2002 | 56 | 0.060 |
Why?
| | Patient Satisfaction | 1 | 2003 | 227 | 0.060 |
Why?
| | Computer Simulation | 1 | 2002 | 215 | 0.060 |
Why?
| | Models, Theoretical | 1 | 2002 | 140 | 0.060 |
Why?
| | Pilot Projects | 1 | 2002 | 475 | 0.060 |
Why?
| | Reproducibility of Results | 1 | 2002 | 742 | 0.050 |
Why?
| | Algorithms | 1 | 2002 | 464 | 0.050 |
Why?
| | Blood Glucose | 1 | 2002 | 509 | 0.050 |
Why?
| | Odds Ratio | 1 | 2019 | 478 | 0.050 |
Why?
| | Databases, Factual | 1 | 2019 | 325 | 0.050 |
Why?
| | Registries | 1 | 2018 | 293 | 0.040 |
Why?
| | Logistic Models | 1 | 2019 | 758 | 0.040 |
Why?
| | Adolescent | 3 | 2014 | 3199 | 0.040 |
Why?
| | Young Adult | 2 | 2014 | 2375 | 0.040 |
Why?
| | Diabetes Complications | 2 | 2010 | 198 | 0.040 |
Why?
| | European Continental Ancestry Group | 2 | 2016 | 1354 | 0.040 |
Why?
| | Longitudinal Studies | 1 | 2017 | 744 | 0.040 |
Why?
| | Infection Control | 1 | 2014 | 15 | 0.040 |
Why?
| | Survival Analysis | 1 | 2016 | 490 | 0.040 |
Why?
| | Genotype | 1 | 2016 | 841 | 0.040 |
Why?
| | Equipment Design | 1 | 2014 | 200 | 0.030 |
Why?
| | Telemedicine | 1 | 2014 | 52 | 0.030 |
Why?
| | Follow-Up Studies | 2 | 2011 | 2226 | 0.030 |
Why?
| | Bone Density Conservation Agents | 1 | 2013 | 20 | 0.030 |
Why?
| | Erythrocyte Transfusion | 1 | 2013 | 28 | 0.030 |
Why?
| | Linear Models | 1 | 2014 | 451 | 0.030 |
Why?
| | Sample Size | 1 | 2012 | 41 | 0.030 |
Why?
| | Accreditation | 1 | 2011 | 12 | 0.030 |
Why?
| | Total Quality Management | 1 | 2011 | 21 | 0.030 |
Why?
| | Double-Blind Method | 1 | 2012 | 533 | 0.030 |
Why?
| | Health Surveys | 1 | 2011 | 208 | 0.030 |
Why?
| | Cross-Sectional Studies | 2 | 2005 | 1343 | 0.030 |
Why?
| | Clinical Trials as Topic | 1 | 2012 | 335 | 0.030 |
Why?
| | Patient Education as Topic | 1 | 2011 | 242 | 0.030 |
Why?
| | Inflammation | 1 | 2012 | 513 | 0.020 |
Why?
| | Cross-Over Studies | 1 | 2007 | 93 | 0.020 |
Why?
| | Feasibility Studies | 1 | 2007 | 271 | 0.020 |
Why?
| | Tomography, Spiral Computed | 1 | 2005 | 25 | 0.020 |
Why?
| | Coronary Angiography | 1 | 2005 | 175 | 0.020 |
Why?
| | Nutrition Assessment | 1 | 2003 | 67 | 0.020 |
Why?
| | Reference Values | 1 | 2003 | 256 | 0.020 |
Why?
| | Nutrition Surveys | 1 | 2003 | 129 | 0.020 |
Why?
| | African Continental Ancestry Group | 1 | 2003 | 411 | 0.010 |
Why?
|
|
Burkart's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|